Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 1
2009 4
2010 1
2017 1
2020 1
2021 3
2022 4
2023 4
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Single agent Talimogene Laherparepvec for stage IIIB-IVM1c melanoma patients: A systematic review and meta-analysis.
Stahlie EHA, Mulder EEAP, Reijers S, Balduzzi S, Zuur CL, Klop WMC, van der Hiel B, Van de Wiel BA, Wouters MWJM, Schrage YM, van Houdt WJ, Grunhagen DJ, van Akkooi ACJ. Stahlie EHA, et al. Among authors: schrage ym. Crit Rev Oncol Hematol. 2022 Jul;175:103705. doi: 10.1016/j.critrevonc.2022.103705. Epub 2022 May 13. Crit Rev Oncol Hematol. 2022. PMID: 35569723 Review.
Neoadjuvant Imatinib in Locally Advanced Gastrointestinal Stromal Tumors (GISTs) is Effective and Safe: Results from a Prospective Single-Center Study with 108 Patients.
van der Burg SJC, van de Wal D, Roets E, Steeghs N, van Sandick JW, Kerst M, van Coevorden F, Hartemink KJ, Veenhof XAAFA, Koenen AM, Ijzerman N, van der Graaf WTA, Schrage YM, van Houdt WJ. van der Burg SJC, et al. Among authors: schrage ym. Ann Surg Oncol. 2023 Dec;30(13):8660-8668. doi: 10.1245/s10434-023-14346-x. Epub 2023 Oct 9. Ann Surg Oncol. 2023. PMID: 37814179
Incidence of unplanned excisions of soft tissue sarcomas in the Netherlands: A population-based study.
Melis AS, Vos M, Schuurman MS, van Dalen T, van Houdt WJ, van der Hage JA, Schrage YM, Been LB, Bonenkamp JB, Bemelmans MHA, Grünhagen DJ, Verhoef C, Ho VKY; Dutch Sarcoma Group (DSG). Melis AS, et al. Among authors: schrage ym. Eur J Surg Oncol. 2022 May;48(5):994-1000. doi: 10.1016/j.ejso.2021.11.123. Epub 2021 Nov 19. Eur J Surg Oncol. 2022. PMID: 34848102
Multimodality treatment of undifferentiated pleomorphic soft tissue sarcoma of the extremity (eUPS) in the elderly.
Bleckman RF, Acem I, van Praag VM, Dorleijn DMJ, Verhoef C, Schrage YM, Haas RML, van de Sande MAJ, The Collaborative Persarc Research Group; collaborative PERSARC research group. Bleckman RF, et al. Among authors: schrage ym. Eur J Surg Oncol. 2022 May;48(5):985-993. doi: 10.1016/j.ejso.2021.12.008. Epub 2021 Dec 15. Eur J Surg Oncol. 2022. PMID: 34930647 Free article.
Intraoperative Near-Infrared Fluorescence Imaging with Indocyanine Green for Identification of Gastrointestinal Stromal Tumors (GISTs), a Feasibility Study.
Kalisvaart GM, Meijer RPJ, Bijlstra OD, Galema HA, de Steur WO, Hartgrink HH, Verhoef C, de Geus-Oei LF, Grünhagen DJ, Schrage YM, Vahrmeijer AL, van der Hage JA. Kalisvaart GM, et al. Among authors: schrage ym. Cancers (Basel). 2022 Mar 18;14(6):1572. doi: 10.3390/cancers14061572. Cancers (Basel). 2022. PMID: 35326721 Free PMC article.
Interferon-gamma signature as prognostic and predictive marker in macroscopic stage III melanoma.
Versluis JM, Blankenstein SA, Dimitriadis P, Wilmott JS, Elens R, Blokx WAM, van Houdt W, Menzies AM, Schrage YM, Wouters MWJM, Sanders J, Broeks A, Scolyer RA, Suijkerbuijk KPM, Long GV, Akkooi ACJV, Blank CU. Versluis JM, et al. Among authors: schrage ym. J Immunother Cancer. 2024 Apr 27;12(4):e008125. doi: 10.1136/jitc-2023-008125. J Immunother Cancer. 2024. PMID: 38677880 Free PMC article.
Local treatment in metastatic GIST patients: A multicentre analysis from the Dutch GIST Registry.
Brink P, Kalisvaart GM, Schrage YM, Mohammadi M, Ijzerman NS, Bleckman RF, Wal T, de Geus-Oei LF, Hartgrink HH, Grunhagen DJ, Verhoef C, Sleijfer S, Oosten AW, Been LB, van Ginkel RJ, Reyners AKL, Bonenkamp HJ, Desar IME, Gelderblom H, van Houdt WJ, Steeghs N, Fiocco M, van der Hage JA. Brink P, et al. Among authors: schrage ym. Eur J Surg Oncol. 2023 Sep;49(9):106942. doi: 10.1016/j.ejso.2023.05.017. Epub 2023 May 23. Eur J Surg Oncol. 2023. PMID: 37246093 Free article.
(Cost-)effectiveness of an individualised risk prediction tool (PERSARC) on patient's knowledge and decisional conflict among soft-tissue sarcomas patients: protocol for a parallel cluster randomised trial (the VALUE-PERSARC study).
Kruiswijk AA, van de Sande MAJ, Haas RL, van den Akker-van Marle EM, Engelhardt EG, Marang-van de Mheen P, van Bodegom-Vos L; VALUE-PERSARC research group. Kruiswijk AA, et al. BMJ Open. 2023 Nov 2;13(11):e074853. doi: 10.1136/bmjopen-2023-074853. BMJ Open. 2023. PMID: 37918933 Free PMC article.
T-VEC for stage IIIB-IVM1a melanoma achieves high rates of complete and durable responses and is associated with tumor load: a clinical prediction model.
Stahlie EHA, Franke V, Zuur CL, Klop WMC, van der Hiel B, Van de Wiel BA, Wouters MWJM, Schrage YM, van Houdt WJ, van Akkooi ACJ. Stahlie EHA, et al. Among authors: schrage ym. Cancer Immunol Immunother. 2021 Aug;70(8):2291-2300. doi: 10.1007/s00262-020-02839-7. Epub 2021 Jan 28. Cancer Immunol Immunother. 2021. PMID: 33507342 Free PMC article.
20 results